Progress in application of digital medical technologies in hepatobiliary diseases

doi:10.3877/cma.j.issn.2095-3232.2026.05.022

Abstract

Abstract:

The proportion of digital medical technologies applied in hepatobiliary diseases has been gradually increased. These technologies can improve preoperative evaluation and precise measurement by using medical imaging, 3D reconstruction and 3D printing, thereby significantly enhancing clinical efficacy of high-risk surgery. In the diagnosis and treatment of hepatobiliary diseases, the application of digital medical technologies including artificial intelligence in medical image analysis, digital angiography and digital portal vein blood flow topology, which promotes early diagnosis and surgical planning of liver tumors. Meantime, the combination of optical imaging and nanotechnology accelerates the development of tumor visualization and combined therapy. Moreover, 3D visualization system has also achieved remarkable efficacy in hepatolithiasis and abdominal trauma surgery. However, digital medical technology still faces multiple challenges such as data processing quality, standardized data collection and ethical risks, highlighting the importance of implementing standardized data collection, quality control and interdisciplinary cooperation, etc. Widespread application prospects of digital medical technologies in hepatobiliary surgery can improve the precision and safety of diagnosis and treatment. In this article, the application of digital medical technology in hepatobiliary diseases was reviewed.

Key words: Digital medicine, Liver tumor, 3D reconstruction, Fluorescent laparoscopy, Hepatic bile duct stone

Wenlong He, Jiajie Lu, Shuai Yan, Zhiqiang Yue, Jinzhu Wu. Progress in application of digital medical technologies in hepatobiliary diseases[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2026, 15(05): 838-843.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhgzwkssxdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-3232.2026.05.022

https://zhgzwkssxdzzz.cma-cmc.com.cn/EN/Y2026/V15/I05/838

Figures/Tables 3

References 35

[1]	方驰华, 田捷, 张鹏, 等. 数字医学技术在肝胆胰外科的应用: 20年历史回顾与未来展望[J]. 中华外科杂志, 2021, 59(10): 807-811.DOI: 10.3760/cma.j.cn112139-20210405-00159.
[2]	杨剑, 伍禧雯, 祝文, 等. 数字智能化微创研究型肝胆胰外科的学科建设[J]. 中华消化外科杂志, 2024, 23(1): 91-97.DOI: 10.3760/cma.j.cn115610-20231130-00227.
[3]	窦科峰, 林智斌. 肝胆管结石治疗理念变迁及技术进步[J]. 中国实用外科杂志, 2024, 44(3): 254-258.DOI: 10.19538/j.cjps.issn1005-2208.2024.03.03.
[4]	Zhu LY, Hou JC, Yang L, et al. Application value of mixed reality in hepatectomy for hepatocellular carcinoma[J]. World J Gastrointest Surg, 2022, 14(1): 36-45.DOI: 10.4240/wjgs.v14.i1.36.
[5]	曹斗斗. 数字减影血管造影技术在肝癌合并肝动脉-门静脉瘘介入治疗中的应用[J]. 当代医学, 2021, 27(20): 127-129.DOI: 10.3969/j.issn.1009-4393.2021.20.053.
[6]	Onashvili N, Mizandari M, Azrumelashvili T, et al. Multidetector computed tomography angiography in the management of transarterial embolization of primary and secondary liver malignancy[J]. Minerva Gastroenterol Dietol, 2016, 62(1): 11-18.
[7]	陈志坚, 俞建达, 池小斌, 等. 三维可视化技术在腹腔镜肝巨大肿瘤切除中的应用价值[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(3): 302-307.DOI: 10.3877/cma.j.issn.2095-3232.2024.03.008.
[8]	Fang C, Zhang P, Qi X. Digital and intelligent liver surgery in the new era: Prospects and dilemmas[J]. EBioMedicine, 2019, 41: 693-701.DOI: 10.1016/j.ebiom.2019.02.017.
[9]	Nishino H, Hatano E, Seo S, et al. Real-time navigation for liver surgery using projection mapping with indocyanine green fluorescence: development of the novel medical imaging projection system[J]. Ann Surg, 2018, 267(6): 1134-1140.DOI: 10.1097/SLA.0000000000002172.
[10]	Wang J, Xu Y, Zhang Y, et al. Safety and effectiveness of fluorescence laparoscopy in precise hepatectomy: a meta-analysis[J]. Photodiagnosis Photodyn Ther, 2023, 42: 103599.DOI: 10.1016/j.pdpdt.2023.103599.
[11]	Wei J, Zhang H, Zhong J, et al. Fluorescent laparoscopic central hepatectomy for liver cancer using indocyanine green negative staining[J]. J Vis Exp, 2023(193): e64869.DOI: 10.3791/64869.
[12]	张森权, 黄傲, 周俭. 晚期肝内胆管癌系统性治疗研究进展[J/OL]. 中华普通外科学文献(电子版), 2024, 18(6): 415-420.DOI: 10.3877/cma.j.issn.1674-0793.2024.06.003.
[13]	常颜信, 张永杰. 肝门部胆管癌外科治疗现状与问题[J]. 中华普通外科杂志, 2025, 40(7): 513-519.DOI: 10.3760/cma.j.cn113855-20250507-00261.
[14]	Piccolo G, Barabino M, Lecchi F, et al. Laparoscopic indocyanine green fluorescence imaging for intrahepatic cholangiocarcinoma[J]. Am Surg, 2023, 89(6): 2577-2582.DOI: 10.1177/00031348221103659.
[15]	方驰华, 刘允怡, 蔡伟. 数字医学技术在我国普通外科应用的现状和前景[J]. 中华外科杂志, 2017, 55(1): 11-14.DOI: 10.3760/cma.j.issn.0529-5815.2017.01.004.
[16]	Chen R, Fang C, Yang J. ASO author reflections: laparoscopic in situ anatomical mesohepatectomy for solitary massive HCC using combined intrafascial and extrafascial approaches with indocyanine green navigation: a new era of digital intelligent liver surgery[J]. Ann Surg Oncol, 2022, 29(3): 2041-2042.DOI: 10.1245/s10434-021-10950-x.
[17]	Zeng X, Yang J, Fang C. ASO author reflections: anatomical extended right posterior sectionectomy: a new surgical strategy for right liver tumor in the digital intelligent liver surgery era[J]. Ann Surg Oncol, 2023, 30(1): 377-378.DOI: 10.1245/s10434-022-12637-3.
[18]	Lin J, Luo W, Fang C, et al. Laparoscopic anatomic combined subsegmentectomy of segment 8 via the tailored strategy using digital intelligent technology[J]. Surg Oncol, 2021, 38: 101622.DOI: 10.1016/j.suronc.2021.101622.
[19]	Tao H, Fang C, Yang J. ASO author reflections: laparoscopic anatomical segment 8 resection using digital intelligent liver surgery technologies: the combination of multiple navigation approaches[J]. Ann Surg Oncol, 2023, 30(12): 7388-7390.DOI: 10.1245/s10434-023-14214-8.
[20]	Chen Q, Chen J, He M, et al. Novel small molecular dye-loaded lipid nanoparticles with efficient near-infrared-II absorption for photoacoustic imaging and photothermal therapy of hepatocellular carcinoma[J]. Biomater Sci, 2019, 7(8): 3165-3177.DOI: 10.1039/c9bm00528e.
[21]	Li Q, Chen K, Huang W, et al. Minimally invasive photothermal ablation assisted by laparoscopy as an effective preoperative neoadjuvant treatment for orthotopic hepatocellular carcinoma[J]. Cancer Lett, 2021, 496: 169-178.DOI: 10.1016/j.canlet.2020.09.024.
[22]	Zhao X, Sun X, Huang W, et al. A microenvironment-responsive FePt probes for imaging-guided Fenton-enhanced radiotherapy of hepatocellular carcinoma[J]. J Nanobiotechnol, 2022, 20(1): 100.DOI: 10.1186/s12951-022-01305-z.
[23]	Ai T, Shang W, Yan H, et al. Near infrared-emitting persistent luminescent nanoparticles for hepatocellular carcinoma imaging and luminescence-guided surgery[J]. Biomaterials, 2018, 167: 216-225.DOI: 10.1016/j.biomaterials.2018.01.031.
[24]	Deng H, Shang W, Wang K, et al. Targeted-detection and sequential-treatment of small hepatocellular carcinoma in the complex liver environment by GPC-3-targeted nanoparticles[J]. J Nanobiotechnol, 2022, 20(1): 156.DOI: 10.1186/s12951-022-01378-w.
[25]	Zhuo J, Wang Y, Hui H, et al. Enhanced glypican-3-targeted identification of hepatocellular carcinoma with liver fibrosis by pre-degrading excess fibrotic collagen[J]. Acta Biomater, 2023, 158: 435-448.DOI: 10.1016/j.actbio.2022.12.062.
[26]	Qi S, Zhang Y, Liu G, et al. Plasmonic-doped melanin-mimic for CXCR4-targeted NIR-II photoacoustic computed tomography-guided photothermal ablation of orthotopic hepatocellular carcinoma[J]. Acta Biomater, 2021, 129: 245-257.DOI: 10.1016/j.actbio.2021.05.034.
[27]	Zhou T, Liang X, Wang P, et al. A hepatocellular carcinoma targeting nanostrategy with hypoxia-ameliorating and photothermal abilities that, combined with immunotherapy, inhibits metastasis and recurrence[J]. ACS Nano, 2020, 14(10): 12679-12696.DOI: 10.1021/acsnano.0c01453.
[28]	Cai W, He B, Hu M, et al. A radiomics-based nomogram for the preoperative prediction of posthepatectomy liver failure in patients with hepatocellular carcinoma[J]. Surg Oncol, 2019, 28: 78-85.DOI: 10.1016/j.suronc.2018.11.013.
[29]	方驰华, 张鹏, 刘允怡, 等. 肝胆外科从数字虚拟人、三维可视化到数字智能化发展的现状[J]. 中华外科杂志, 2020, 58(1): 17-21.DOI: 10.3760/cma.j.issn.0529-5815.2020.01.005.
[30]	Digital MAOCMA, Digital ISPCOCRH, Liver CPCOCMDA, et al. Guidelines for application of computer-assisted indocyanine green molecular fluorescence imaging in diagnosis and surgical navigation of liver tumors (2019)[J]. Nan Fang Yi Ke Da Xue Xue Bao, 2019, 39(10): 1127-1140.DOI: 10.12122/j.issn.1673-4254.2019.10.01.
[31]	中华医学会数字医学分会, 中华医学会外科学分会胆道外科学组, 中国医师协会外科医师分会胆道外科医师委员会, 等. 肝胆管结石三维可视化精准诊治专家共识(2019版)[J]. 中国实用外科杂志, 2019, 39(10): 1001-1009.DOI: 10.19538/j.cjps.issn1005-2208.2019.10.01.
[32]	刘洋, 郭伟. 数字医学技术在肝胆外科的临床应用[J/OL]. 中华肝脏外科手术学电子杂志, 2013, 2(4): 4-6.DOI: 10.3969/cma.j.issn.2095-3232.2013.04.002.
[33]	吴性江, 黎介寿. 腹部血管损伤的控制性外科治疗[J]. 腹部外科, 2009, 22(2): 70-71.DOI: 10.3969/j.issn.1003-5591.2009.02.002.
[34]	中华医学会数字医学分会, 中国研究型医院学会, 数字医学临床外科专业委员会. 腹膜后肿瘤三维可视化精准诊治专家共识(2018版)[J]. 中国实用外科杂志, 2018, 38(12): 1347-1353.DOI: 10.19538/j.cjps.issn1005-2208.2018.12.03.
[35]	商搏世, 石光林, 徐洪来, 等. 三维可视化及3D打印在精准肝切除手术中的应用[J]. 广西科技大学学报, 2021, 32(3): 48-52.DOI: 10.16375/j.cnki.cn45-1395/t.2021.03.008.

Please choose a citation manager

Content to export